EMPLOYMENT AGREEMENTEmployment Agreement • March 7th, 2014 • Zogenix, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 7th, 2014 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into by and between Zogenix, Inc., a Delaware corporation (the “Company”), and Bradley Stuart Galer, M.D. (“Executive”), and shall be effective as of December 17th, 2013 (the “Effective Date”).
BATTELLE/ZOGENIX CO-MARKETING AND DEVELOPMENT SERVICES AGREEMENTMarketing and Development Services Agreement • March 7th, 2014 • Zogenix, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 7th, 2014 Company Industry JurisdictionThis Co-Marketing and Development Services Agreement (“Agreement”) is made and entered into as of the 26th day of November, 2013 and is by and between Battelle Memorial Institute (“Battelle”) and Zogenix, Inc. (“Zogenix”). Battelle and Zogenix are individually referred to as a “Party” and collectively referred to as the “Parties”.
DEVELOPMENT AND OPTION AGREEMENTDevelopment and Option Agreement • March 7th, 2014 • Zogenix, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 7th, 2014 Company Industry JurisdictionTHIS DEVELOPMENT AND OPTION AGREEMENT (this “Agreement”) is made as of November 1, 2013 (the “Effective Date”), by and between ALTUS FORMULATION INC., a Quebec company having its principal place of business at 17800 Rue Lapointe, Mirabel Quebec J7J 1P3, Canada (“Altus”), and ZOGENIX, INC., a Delaware corporation having its principal place of business at 12400 High Bluff Drive, Suite 650, San Diego, CA 92130 USA (“Zogenix”). Each of Altus and Zogenix are sometimes referred to herein individually as a “Party” and together as the “Parties”.
EMPLOYMENT TRANSITION AGREEMENTEmployment Transition Agreement • March 7th, 2014 • Zogenix, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 7th, 2014 Company Industry JurisdictionTHIS EMPLOYMENT TRANSITION AGREEMENT (this “Agreement”) is entered into by and between Zogenix, Inc., a Delaware corporation (the “Company”), and Cynthia Y. Robinson, Ph.D. (“Employee”), and shall be effective as of November 1, 2013 (the “Effective Date”).